David Turner to Prostatic Neoplasms
This is a "connection" page, showing publications David Turner has written about Prostatic Neoplasms.
Connection Strength
0.988
-
AGE metabolites: a biomarker linked to cancer disparity? Cancer Epidemiol Biomarkers Prev. 2014 Oct; 23(10):2186-91.
Score: 0.302
-
ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype. Carcinogenesis. 2012 Mar; 33(3):572-80.
Score: 0.254
-
Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression. Prostate. 2011 Dec; 71(16):1723-35.
Score: 0.240
-
ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer. Expert Rev Anticancer Ther. 2008 Jan; 8(1):33-42.
Score: 0.192